» Articles » PMID: 15490093

Combined Use of Positive and Negative Immunomagnetic Isolation Followed by Real-time RT-PCR for Detection of the Circulating Tumor Cells in Patients with Colorectal Cancers

Overview
Specialty General Medicine
Date 2004 Oct 19
PMID 15490093
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

To establish a novel molecular diagnostic method of detecting circulating tumor cells (CTCs) LS174T colon cancer cells were serially diluted with normal blood. Additional peripheral blood samples were collected from 25 patients with colorectal carcinoma. Mononuclear cells (MNCs) were collected, equally divided into four parts, and then cancer cells were enriched by four methods: method A, nonimmunobead method; method B, negative immunobead method: CD45 immunomagnetic beads were used to deplete the leukocytes; method C, positive immunobead method: Ber-EP4 immunomagnetic beads were used to enrich cancer cells; method D, negative-and-positive immunobead method: CD45 immunomagnetic beads were first used to deplete the leukocytes from MNC and then Ber-EP4 immunomagnetic beads were used to enrich cancer cells. Finally, real-time quantitative RT-PCR was used to monitor mRNA expression of beta2-mircoglobulin (beta2M) and carcinoembryonic antigen (CEA). The relative CEA mRNA values were corrected with reference to beta2M mRNA, to CEA mRNA/beta2M mRNA ratios according to a CEA mRNA external standards prepared with tenfold serial dilutions (1-10(4) IS174T cells) of cDNA and beta2M mRNA external standards prepared with tenfold serial dilutions (10(2)-10(7) leukocytes) of cDNA. In recovery experiments a significant correlation between the number of cancer cells and CEA mRNA expression was found when CD45 or Ber-EP4 immunomagnetic beads were used alone. A highly significant correlation was found when CD45 and Ber-EP4 immunomagnetic beads were used successively. The sensitivity of method D was one cancer cell per milliliter of blood. Circulating cancer cells were detected in 19 of 25 patients with colorectal cancers. The relative CEA mRNA value obtained by method D was the smallest. The positive detection rate of circulating cancer cells in patients at Dukes' B, C, and D stages were 25.0% (1/4), 83.3% (10/12), and 88.9% (8/9). Combinative use of immunomagnetic isolation followed by real-time RT-PCR is a useful technique to detect circulating tumor cells in patients with colorectal carcinomas. Applying negative and positive immunomagnetic beads successively yields the highest correlation with amount of tumor cells.

Citing Articles

Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review.

Nie C, Shaw I, Chen C J Pharm Anal. 2024; 13(12):1429-1451.

PMID: 38223444 PMC: 10785256. DOI: 10.1016/j.jpha.2023.08.009.


Liquid Biopsy Biomarkers for Immunotherapy in Non-Small Cell Lung Carcinoma: Lessons Learned and the Road Ahead.

Hita-Millan J, Carracedo A, Fernandez-Rozadilla C J Pers Med. 2021; 11(10).

PMID: 34683113 PMC: 8540302. DOI: 10.3390/jpm11100971.


Enumeration and molecular characterization of circulating tumor cells enriched by microcavity array from stage III non-small cell lung cancer patients.

Cohen E, Jayachandran G, Gao H, Qiao W, Liu S, He J Transl Lung Cancer Res. 2020; 9(5):1974-1985.

PMID: 33209617 PMC: 7653158. DOI: 10.21037/tlcr-20-841.


Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.

Vafaei S, Fattahi F, Ebrahimi M, Janani L, Shariftabrizi A, Madjd Z Cancer Manag Res. 2019; 11:8669-8698.

PMID: 31576171 PMC: 6768129. DOI: 10.2147/CMAR.S219699.


The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course.

Taddei A, Castiglione F, Ringressi M, Niccolai E, Tofani L, Boni L Mediators Inflamm. 2015; 2015:931784.

PMID: 26556959 PMC: 4628650. DOI: 10.1155/2015/931784.


References
1.
Hardingham J, Kotasek D, Farmer B, Butler R, Mi J, Sage R . Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res. 1993; 53(15):3455-8. View

2.
Degan M, Mazzocco F, Di Francia R, Rossi F, Pinto A, Gattei V . Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia. Diagn Mol Pathol. 2000; 9(2):98-109. DOI: 10.1097/00019606-200006000-00006. View

3.
Raynor M, Stephenson S, Walsh D, Pittman K, Dobrovic A . Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells. BMC Cancer. 2002; 2:14. PMC: 115840. DOI: 10.1186/1471-2407-2-14. View

4.
Burchill S, Bradbury M, Pittman K, Southgate J, Smith B, Selby P . Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995; 71(2):278-81. PMC: 2033587. DOI: 10.1038/bjc.1995.56. View

5.
Ghossein R, Rosai J . Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer. 1996; 78(1):10-6. DOI: 10.1002/(SICI)1097-0142(19960701)78:1<10::AID-CNCR3>3.0.CO;2-L. View